Vesetranszplantáció utáni szénhidrátanyagcsere-változások és annak hatásai a cardiovascularis rizikóra [Changes in carbohydrate metabolism after kidney transplantation and their effects on cardiovascular risk]

Introduction: Cardiovascular disease is the major cause of deaths after transplantation, with diabetes mellitus being the main risk factor in development. Aim: The aim of our study was to assess the prevalence of new onset diabetes mellitus in connection with the cardiovascular risk predicted by the...

Full description

Saved in:
Bibliographic Details
Main Authors: Borda Bernadett
Szederkényi Edit
Hódi Zoltán
Ottlakán Aurél
Szabó Viktor
Lázár György ifj
Format: Article
Published: 2017
Series:ORVOSI HETILAP 158 No. 38
doi:10.1556/650.2017.30833

mtmt:3277668
Online Access:http://publicatio.bibl.u-szeged.hu/16101
LEADER 02303nab a2200265 i 4500
001 publ16101
005 20190711143619.0
008 190711s2017 hu o 0|| magyar d
022 |a 0030-6002 
024 7 |a 10.1556/650.2017.30833  |2 doi 
024 7 |a 3277668  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a magyar 
100 1 |a Borda Bernadett 
245 1 0 |a Vesetranszplantáció utáni szénhidrátanyagcsere-változások és annak hatásai a cardiovascularis rizikóra [Changes in carbohydrate metabolism after kidney transplantation and their effects on cardiovascular risk]  |h [elektronikus dokumentum] /  |c  Borda Bernadett 
260 |c 2017 
300 |a 1512-1516 
490 0 |a ORVOSI HETILAP  |v 158 No. 38 
520 3 |a Introduction: Cardiovascular disease is the major cause of deaths after transplantation, with diabetes mellitus being the main risk factor in development. Aim: The aim of our study was to assess the prevalence of new onset diabetes mellitus in connection with the cardiovascular risk predicted by the HEART Score. Method: 44 patients were involved in our study; after overview of baseline data, OGTT was performed, followed by patient classification into the following groups: normal, impaired fasting glucose/impaired glucose tolerance, and new onset diabetes mellitus. Insulin resistance and kidney function were also assessed. Results: Concerning baseline data, cold ischemic time (p = 0.016), body weight (p = 0.035), BMI (p = 0.025), and HbA1C (p = 0.0024) proved to be significantly different between normal and diabetic patients. Significant difference was found based on HOMA IR between the two groups 1.69±0.51 vs 6.46±1.42; p = 0.0017). Based on the HEART Score, patients with new onset diabetes mellitus were put into Group 3, which also reflects the risk which diabetes carries for the development of cardiovascular diseases. Conclusion: Cardiovascular risk can be decreased with increased allograft survival by early diagnosis and management of diabetes. 
700 0 1 |a Szederkényi Edit  |e aut 
700 0 1 |a Hódi Zoltán  |e aut 
700 0 1 |a Ottlakán Aurél  |e aut 
700 0 1 |a Szabó Viktor  |e aut 
700 0 1 |a Lázár György ifj.  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16101/1/Borda_Vesetranszplantacioutani.pdf  |z Dokumentum-elérés